XOSPATA
Live / Registered — Registered — international registration renewed (as of 16 Jan 2024)
What this means for you
Registered since 30 May 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 ten-year affidavit of use is due by 30 May 2027, and its filing window is open now).
Record
- Serial number
- 79199845
- Registration number
- 5211443
- Mark type
- Word mark
- Filed
- 14 Oct 2016
- Published for opposition
- 14 Mar 2017
- Registered
- 30 May 2017
- Next maintenance filing
- §71 ten-year affidavit of use, due by 30 May 2027 (grace period to 30 Nov 2027)
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Astellas Pharma Inc., Tokyo, JP
- Astellas Pharma Inc., JP
- Astellas Pharma Inc., JP
Prosecution history
- 09 Jul 2026 — INTERNATIONAL REGISTRATION RENEWED
- 30 May 2026 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 14 Apr 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 14 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Apr 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 14 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Jul 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Jul 2024 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 09 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 16 Jan 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 22 Dec 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL